- Home
- MRUS vs SLVM Comparison
MRUS vs SLVM Comparison
Compare MRUS & SLVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- SLVM
- Stock Information
- Founded
- MRUS 2003
- SLVM 1898
- Country
- MRUS Netherlands
- SLVM United States
- Employees
- MRUS N/A
- SLVM N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- SLVM Paper
- Sector
- MRUS Health Care
- SLVM Basic Materials
- Exchange
- MRUS Nasdaq
- SLVM Nasdaq
- Market Cap
- MRUS 2.7B
- SLVM 2.4B
- IPO Year
- MRUS 2016
- SLVM N/A
- Fundamental
- Price
- MRUS $56.07
- SLVM $52.94
- Analyst Decision
- MRUS Strong Buy
- SLVM Hold
- Analyst Count
- MRUS 15
- SLVM 3
- Target Price
- MRUS $88.87
- SLVM $85.67
- AVG Volume (30 Days)
- MRUS 1.6M
- SLVM 338.3K
- Earning Date
- MRUS 05-07-2025
- SLVM 05-09-2025
- Dividend Yield
- MRUS N/A
- SLVM 3.40%
- EPS Growth
- MRUS N/A
- SLVM 45.44
- EPS
- MRUS N/A
- SLVM 6.82
- Revenue
- MRUS $54,732,000.00
- SLVM $3,689,000,000.00
- Revenue This Year
- MRUS $39.00
- SLVM N/A
- Revenue Next Year
- MRUS $7.48
- SLVM $0.14
- P/E Ratio
- MRUS N/A
- SLVM $7.76
- Revenue Growth
- MRUS 42.77
- SLVM 0.11
- 52 Week Low
- MRUS $33.19
- SLVM $51.60
- 52 Week High
- MRUS $61.28
- SLVM $98.02
- Technical
- Relative Strength Index (RSI)
- MRUS 66.86
- SLVM 37.44
- Support Level
- MRUS $49.46
- SLVM $54.32
- Resistance Level
- MRUS $56.74
- SLVM $55.70
- Average True Range (ATR)
- MRUS 3.37
- SLVM 1.53
- MACD
- MRUS 1.57
- SLVM -0.03
- Stochastic Oscillator
- MRUS 91.31
- SLVM 8.19
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About SLVM Sylvamo Corporation
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.